125 related articles for article (PubMed ID: 20852057)
1. The nitric oxide donor molsidomine rescues cardiac function in rats with chronic kidney disease and cardiac dysfunction.
Bongartz LG; Braam B; Verhaar MC; Cramer MJ; Goldschmeding R; Gaillard CA; Steendijk P; Doevendans PA; Joles JA
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2037-45. PubMed ID: 20852057
[TBL] [Abstract][Full Text] [Related]
2. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease.
Lima Posada I; Soulié M; Stephan Y; Palacios Ramirez R; Bonnard B; Nicol L; Pitt B; Kolkhof P; Mulder P; Jaisser F
J Am Heart Assoc; 2024 Jun; 13(12):e032971. PubMed ID: 38842271
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.
Wu-Wong JR; Chen YW; Wessale JL
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F309-19. PubMed ID: 25503724
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na
Bai XJ; Hao JT; Wang J; Zhang WF; Yan CP; Zhao JH; Zhao ZQ
Pharmacol Rep; 2018 Feb; 70(1):60-68. PubMed ID: 29331788
[TBL] [Abstract][Full Text] [Related]
6. Transient nitric oxide reduction induces permanent cardiac systolic dysfunction and worsens kidney damage in rats with chronic kidney disease.
Bongartz LG; Braam B; Verhaar MC; Cramer MJ; Goldschmeding R; Gaillard CA; Doevendans PA; Joles JA
Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R815-23. PubMed ID: 20032261
[TBL] [Abstract][Full Text] [Related]
7. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide donor molsidomine favors features of atherosclerotic plaque stability and reduces myocardial infarction in mice.
Roth L; Van der Donckt C; Emini Veseli B; Van Dam D; De Deyn PP; Martinet W; Herman AG; De Meyer GRY
Vascul Pharmacol; 2019; 118-119():106561. PubMed ID: 31085310
[TBL] [Abstract][Full Text] [Related]
9. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
Bartunek J; Dempsey S; Weinberg EO; Ito N; Tajima M; Rohrbach S; Lorell BH
J Am Coll Cardiol; 1998 Aug; 32(2):528-35. PubMed ID: 9708487
[TBL] [Abstract][Full Text] [Related]
10. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload.
Borgdorff MA; Bartelds B; Dickinson MG; van Wiechen MP; Steendijk P; de Vroomen M; Berger RM
Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H361-9. PubMed ID: 24878769
[TBL] [Abstract][Full Text] [Related]
12. Effect of molsidomine and L-arginine in cyclosporine nephrotoxicity: role of nitric oxide.
Chander V; Chopra K
Toxicology; 2005 Feb; 207(3):463-74. PubMed ID: 15664273
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of NHE3-mediated Sodium Absorption in the Gut Reduced Cardiac End-organ Damage Without Deteriorating Renal Function in Obese Spontaneously Hypertensive Rats.
Linz B; Hohl M; Reil JC; Böhm M; Linz D
J Cardiovasc Pharmacol; 2016 Mar; 67(3):225-31. PubMed ID: 26727380
[TBL] [Abstract][Full Text] [Related]
14. Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model.
Benigni A; Zoja C; Noris M; Corna D; Benedetti G; Bruzzi I; Todeschini M; Remuzzi G
Am J Kidney Dis; 1999 Apr; 33(4):746-53. PubMed ID: 10196019
[TBL] [Abstract][Full Text] [Related]
15. The NO donor molsidomine reduces endothelin-1 gene expression in chronic hypoxic rat lungs.
Blumberg FC; Wolf K; Sandner P; Lorenz C; Riegger GA; Pfeifer M
Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L258-63. PubMed ID: 11159004
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.
Morooka H; Iwanaga Y; Tamaki Y; Takase T; Akahoshi Y; Nakano Y; Fujiki H; Miyazaki S
Circ Heart Fail; 2012 Jul; 5(4):484-92. PubMed ID: 22628529
[TBL] [Abstract][Full Text] [Related]
17. Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction.
Connelly KA; Zhang Y; Desjardins JF; Nghiem L; Visram A; Batchu SN; Yerra VG; Kabir G; Thai K; Advani A; Gilbert RE
Cardiovasc Diabetol; 2020 Feb; 19(1):13. PubMed ID: 32035482
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
Itoh T; Haruna M; Abe K
Exp Physiol; 2007 Jan; 92(1):147-59. PubMed ID: 17030559
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure.
Westermann D; Riad A; Richter U; Jäger S; Savvatis K; Schuchardt M; Bergmann N; Tölle M; Nagorsen D; Gotthardt M; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2009 Sep; 104(5):499-509. PubMed ID: 19255799
[TBL] [Abstract][Full Text] [Related]
20. Molsidomine, a nitric oxide donor and L-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure.
Chander V; Chopra K
Biochim Biophys Acta; 2005 May; 1723(1-3):208-14. PubMed ID: 15777642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
